February 22, 2024 News by Margarida Maia, PhD Complement protein activation is linked to more severe MS Complement proteins, especially when activated in the brain and spinal cord, may contribute to nerve cell damage and more severe multiple sclerosis (MS) symptoms, a study that offers insights into a possible therapeutic target suggests. The study, āComplement Activation Is Associated With Disease Severity in Multiple Sclerosis,ā was…
October 19, 2021 News by Marta Figueiredo, PhD #ECTRIMS2021 ā Problems in Thalamus Linked to Severe Progressive MS Editorās note: TheĀ Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13ā15. GoĀ here to see the latest stories from the conference. In people with progressive multiple sclerosis (MS), neuron loss…
June 29, 2021 News by Patricia Inacio, PhD Progressive MS Projects Earn Research Challenge Awards The Multiple Sclerosis Society of Canada has granted itsĀ International Progressive MS Alliance (Alliance) Research Challenge Awards to 19 researchers for their work on progressive forms of multiple sclerosis (MS). Among them is Jennifer Gommerman, PhD, a professor at the University of Toronto, in Canada, who will use…
November 4, 2019 News by Ana Pena PhD Mutations in 3 Genes Linked to Vision Loss and MS Severity in Hopkins Study Mutations in genes related to the immune system’s first line of defense are associated with a greater likelihood of more severe forms of multiple sclerosis (MS) linked to faster vision loss, a team led by Johns Hopkins Medicine researchers report. Combining high-resolution eye scans and genetic tests,…
September 14, 2016 News by Patricia Silva, PhD #ECTRIMS2016 – Eye Imaging, Genetics Link Immune Complement Factors to MS Progression Genes that encode what are called “complement” immune factors are linked to the breakdown of the retina in multiple sclerosis (MS) patients ā a measure that, in turn, predicts brain damage and loss of eyesight. The study, a joint effort between researchers from Johns Hopkins School of Medicine,…
July 11, 2016 News by Patricia Silva, PhD Workings of Common Statin, Simvastatin, Explored in Ways Relevant to Multiple Sclerosis One of the worldās most commonly used medications ā the cholesterol-lowering drug simvastatin ā was found to affect the immune system in a way that can be explored to treat inflammatory diseases such as multiple sclerosis (MS). Researchers have earlier noted that simvastatin, a cholesterol-lowering drug, is beneficial for MS…
June 28, 2016 News by Patricia Silva, PhD MS Progression May Be Tied to Workings of Immune Complement System in Brain Lesions The complement system, a part of our non-adaptable (innate) immune defenses,Ā is activated in lesions inside the brainās gray matter and may well contribute to the relentless progression of multiple sclerosis (MS), researchers report. The findings offer newĀ insights into mechanisms driving the development of this disease ā particularly itsĀ primary progressive forms.
April 6, 2015 News by Patricia Silva, PhD Central Immune System Component Found to be Related to MS Neurodegeneration, Clinical Disability A recentĀ study published inĀ PLOS ONEĀ provides new insights into the relationship between the immune system and neurodegeneration and clinical disability in multiple sclerosis (MS). A team of researchers led by Dr.Ā Shahin Aeinehband from theĀ Neuroimmunology Unit at theĀ Karolinska Institutet in Sweden looked at the association between…